Jonathan A Schulz, Sean D Regnier, Tyler G Erath, Lindsey C Mullis, Austin Nugent, Gary S Atwood, Andrea C Villanti
INTRODUCTION: People with disabilities disproportionately use tobacco products. However, little is known about cessation interventions tailored for people with disabilities. The objective of this study was to conduct a systematic review of smoking cessation interventions for adults with disabilities.
METHODS: Six electronic databases (Cochrane, CINAHL Plus [EBSCOhost], Embase [Ovid], Medline [Ovid], PsycINFO [Ovid], and Web of Science) were searched to identify eligible interventions for people with disabilities (e.g., vision, hearing, mobility, communication, cognition, self-care) through July 2023. Two independent coders evaluated the records and extracted data from studies that met inclusion criteria. Qualitative synthesis was conducted on the included studies in 2023.
RESULTS: One randomized controlled trial and one nonrandomized study met the inclusion criteria. Both studies used mindfulness-based procedures to reduce cigarette use in adults with mild intellectual disability. The outcome was defined as self-reported cigarette use at follow-up, which ranged from 1 year to 3 years. Limited information was provided on how the interventions were tailored to meet the unique needs of people with disabilities in either study.
CONCLUSION: Two interventions conducted in adults with mild intellectual disability showed promising results using mindfulness-based procedures; however, the studies did not address barriers reported by people with disabilities, nor tailor the interventions to meet the needs of the target population. Research is needed to address tobacco use disparities among people with a range of disabilities. Current cessation interventions would be enhanced by integrating disability identifiers alongside other demographic information in future studies and reporting subgroup analyses in adults with disabilities.
J Intellect Disabil Res. 2013 May;57(5):393-408
[PMID:
22458301]
J Intellect Disabil Res. 1997 Oct;41 ( Pt 5):416-21
[PMID:
9373822]
Disabil Health J. 2016 Jan;9(1):145-9
[PMID:
26365086]
JAMA Intern Med. 2020 Nov 1;180(11):1472-1480
[PMID:
32955554]
Tob Control. 2007 Dec;16 Suppl 1:i3-8
[PMID:
18048627]
BMJ. 2019 Aug 28;366:l4898
[PMID:
31462531]
BMJ Open. 2023 Mar 22;13(3):e066700
[PMID:
36948548]
BMC Public Health. 2018 Mar 15;18(1):355
[PMID:
29544470]
Am J Prev Med. 2010 Dec;39(6):564-74
[PMID:
21084078]
Prev Med. 2022 Dec;165(Pt B):107209
[PMID:
35995105]
Intellect Dev Disabil. 2020 Jun 1;58(3):241-250
[PMID:
32484885]
Am J Prev Med. 2022 Oct;63(4):552-563
[PMID:
35753866]
Respir Care. 2013 Nov;58(11):1955-62
[PMID:
23431304]
Disabil Health J. 2011 Apr;4(2):59-67
[PMID:
21419369]
J Am Coll Health. 2022 Oct;70(7):2079-2084
[PMID:
33151844]
Psychol Health Med. 2014;19(4):410-9
[PMID:
24040938]
BMC Psychiatry. 2017 Jul 14;17(1):252
[PMID:
28705244]
JAMA Netw Open. 2019 Apr 5;2(4):e192514
[PMID:
31002320]
Lancet. 2021 Jul 31;398(10298):443-455
[PMID:
34302764]
Disabil Health J. 2020 Jul;13(3):100882
[PMID:
31917121]
Nicotine Tob Res. 2016 Dec;18(12):2177-2184
[PMID:
27245237]
J Addict Res Ther. 2014;5(4):
[PMID:
35492032]
Am J Prev Med. 2021 Mar;60(3 Suppl 2):S163-S171
[PMID:
33663704]
Am J Prev Med. 2003 Nov;25(4):363-7
[PMID:
14580641]
Addiction. 2010 Jul;105(7):1176-89
[PMID:
20491721]
Disabil Health J. 2014 Jan;7(1):114-8
[PMID:
24411515]
Glob J Health Sci. 2012 Sep 09;4(6):99-108
[PMID:
23121746]
Int J Clin Pract. 2021 Dec;75(12):e14894
[PMID:
34541754]
Sci Rep. 2019 Dec 20;9(1):19488
[PMID:
31862899]
J Consult Clin Psychol. 2020 Oct;88(10):951-964
[PMID:
33048571]
Tob Use Insights. 2019 Jan 23;12:1179173X18825075
[PMID:
30718966]
Am J Public Health. 2002 Jun;92(6):990-6
[PMID:
12036794]
Lancet Psychiatry. 2020 Sep;7(9):762-774
[PMID:
32828166]
Cochrane Database Syst Rev. 2018 May 31;5:CD000146
[PMID:
29852054]
J Adv Nurs. 2021 Aug;77(8):3331-3342
[PMID:
33896036]
Prev Med. 2022 Dec;165(Pt B):107012
[PMID:
35248683]
BMJ. 2016 Oct 12;355:i4919
[PMID:
27733354]
J Wound Ostomy Continence Nurs. 2016 Sep-Oct;43(5):483-7
[PMID:
27607744]
Res Dev Disabil. 2011 May-Jun;32(3):1180-5
[PMID:
21288689]
MMWR Morb Mortal Wkly Rep. 2018 Aug 17;67(32):882-887
[PMID:
30114005]
Am J Prev Med. 2004 Oct;27(3):258-60
[PMID:
15450640]
JAMA. 2021 Jan 19;325(3):265-279
[PMID:
33464343]
Qual Life Res. 2016 Mar;25(3):669-85
[PMID:
26310284]
Am J Prev Med. 2020 Jul;59(1):123-136
[PMID:
32418800]
BMJ. 2009 Jul 21;339:b2535
[PMID:
19622551]
Sci Transl Med. 2011 May 11;3(82):82cm12
[PMID:
21562227]
PLoS One. 2022 Dec 15;17(12):e0279065
[PMID:
36520847]
Drug Alcohol Depend. 2023 Feb 1;243:109738
[PMID:
36535098]
Nicotine Tob Res. 2003 Feb;5(1):13-25
[PMID:
12745503]
Health Aff (Millwood). 2011 Oct;30(10):1947-54
[PMID:
21976339]
Psychol Bull. 1992 Jul;112(1):155-9
[PMID:
19565683]
Am Ann Deaf. 2010 Spring;155(1):96-102
[PMID:
20503910]